Literature DB >> 9391879

Low frequency of BRCA1 germline mutations in 45 German breast/ovarian cancer families.

U Hamann1, M Häner, U Stosiek, G Bastert, R J Scott.   

Abstract

In this study we investigated 45 German breast/ovarian cancer families for germline mutations in the BRCA1 gene. We identified four germline mutations in three breast cancer families and in one breast-ovarian cancer family. among these were one frameshift mutation, one nonsense mutation, one novel splice site mutation, and one missense mutation. The missense mutation was also found in 2.8% of the general population, suggesting that it is not disease associated. The average age of disease onset in those families harbouring causative mutations was between 32.3 and 37.4 years, whereas the family harbouring the missense mutation had an average age of onset of 51.2 years. These findings show that BRCA1 is implicated in a small fraction of breast/ovarian cancer families suggesting the involvement of another susceptibility gene(s).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9391879      PMCID: PMC1051113          DOI: 10.1136/jmg.34.11.884

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  29 in total

1.  Hormone-dependent regulation of BRCA1 in human breast cancer cells.

Authors:  J M Gudas; H Nguyen; T Li; K H Cowan
Journal:  Cancer Res       Date:  1995-10-15       Impact factor: 12.701

2.  The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues.

Authors:  S T Marquis; J V Rajan; A Wynshaw-Boris; J Xu; G Y Yin; K J Abel; B L Weber; L A Chodosh
Journal:  Nat Genet       Date:  1995-09       Impact factor: 38.330

3.  A somatic BRCA1 mutation in an ovarian tumour.

Authors:  L Hosking; J Trowsdale; H Nicolai; E Solomon; W Foulkes; G Stamp; E Signer; A Jeffreys
Journal:  Nat Genet       Date:  1995-04       Impact factor: 38.330

4.  Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice.

Authors:  T F Lane; C Deng; A Elson; M S Lyu; C A Kozak; P Leder
Journal:  Genes Dev       Date:  1995-11-01       Impact factor: 11.361

5.  Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer.

Authors:  L H Castilla; F J Couch; M R Erdos; K F Hoskins; K Calzone; J E Garber; J Boyd; M B Lubin; M L Deshano; L C Brody
Journal:  Nat Genet       Date:  1994-12       Impact factor: 38.330

6.  Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families.

Authors:  J Simard; P Tonin; F Durocher; K Morgan; J Rommens; S Gingras; C Samson; J F Leblanc; C Bélanger; F Dion
Journal:  Nat Genet       Date:  1994-12       Impact factor: 38.330

7.  A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families.

Authors:  O Serova; M Montagna; D Torchard; S A Narod; P Tonin; B Sylla; H T Lynch; J Feunteun; G M Lenoir
Journal:  Am J Hum Genet       Date:  1996-01       Impact factor: 11.025

8.  High allele loss rates at 17q12-q21 in breast and ovarian tumors from BRCAl-linked families. The Breast Cancer Linkage Consortium.

Authors:  R S Cornelis; S L Neuhausen; O Johansson; A Arason; D Kelsell; B A Ponder; P Tonin; U Hamann; A Lindblom; P Lalle
Journal:  Genes Chromosomes Cancer       Date:  1995-07       Impact factor: 5.006

9.  Rapid detection of BRCA1 mutations by the protein truncation test.

Authors:  F B Hogervorst; R S Cornelis; M Bout; M van Vliet; J C Oosterwijk; R Olmer; B Bakker; J G Klijn; H F Vasen; H Meijers-Heijboer
Journal:  Nat Genet       Date:  1995-06       Impact factor: 38.330

10.  Somatic mutations in the BRCA1 gene in sporadic ovarian tumours.

Authors:  S D Merajver; T M Pham; R F Caduff; M Chen; E L Poy; K A Cooney; B L Weber; F S Collins; C Johnston; T S Frank
Journal:  Nat Genet       Date:  1995-04       Impact factor: 38.330

View more
  4 in total

1.  High frequency of BRCA1/2 germline mutations in 42 Belgian families with a small number of symptomatic subjects.

Authors:  G Goelen; E Teugels; M Bonduelle; B Neyns; J De Grève
Journal:  J Med Genet       Date:  1999-04       Impact factor: 6.318

Review 2.  A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.

Authors:  Fatemeh Karami; Parvin Mehdipour
Journal:  Biomed Res Int       Date:  2013-11-07       Impact factor: 3.411

3.  Intronic TP53 Germline Sequence Variants Modify the Risk in German Breast/Ovarian Cancer Families.

Authors:  Xuan Liu; Hans-Peter Sinn; Hans Ulrich Ulmer; Rodney J Scott; Ute Hamann
Journal:  Hered Cancer Clin Pract       Date:  2004-07-15       Impact factor: 2.857

4.  Five recurrent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families.

Authors:  Mateja Krajc; Erik Teugels; Janez Zgajnar; Guido Goelen; Nikola Besic; Srdjan Novakovic; Marko Hocevar; Jacques De Grève
Journal:  BMC Med Genet       Date:  2008-09-10       Impact factor: 2.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.